IREN
IREN Limited
There isn't enough reported data to score IREN yet.
PDLB
Ponce Financial Group, Inc.
PDLB's fundamentals are strong and it looks cheap: trading at 12x earnings, about half its usual 22x. Analysts expect strong earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
PDLB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PDLB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PDLB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
PDLB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $22.20 | — |
| Current | 12x | $22.20 | — |
| Cheap | 15x | $27.86 | +26% |
| Fair | 22x | $42.18 | +90% |
| Expensive | 38x | $72.93 | +229% |
Historical ranges are pointers, not guarantees.
PDLB's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PDLB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for PDLB, with profitability holding steady.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
PDLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.99 | +4.7% |
| Q3 2026 | $1.90 | +116% |
| Q2 2026 | $1.41 | +99% |
| Q1 2026 | $1.31 | +118% |
| Q4 2025 | $1.20 | +161% |
| Q3 2025 | $0.88 | +138% |
| Q2 2025 | $0.71 | +82% |
| Q1 2025 | $0.60 | +140% |
| Q4 2024 | $0.46 | +207% |
PDLB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
PDLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $34.8M | +30% |
| Q2 2026 | $31.6M | +19% |
| Q1 2026 | $30.3M | +23% |
| Q4 2025 | $31.4M | +38% |
| Q3 2025 | $26.7M | +33% |
| Q2 2025 | $26.5M | +31% |
| Q1 2025 | $24.6M | +20% |
| Q4 2024 | $22.8M | +24% |
PDLB's revenue has grown year over year for eight quarters in a row: $35M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +2.8 points |
| Q2 2026 | 36% | +5.6 points |
| Q1 2026 | 38% | +5.1 points |
| Q4 2025 | 44% | +24 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 30% | +8.4 points |
| Q1 2025 | 32% | +14 points |
| Q4 2024 | 20% | +14 points |
PDLB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
PDLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.4M | +1603% |
| Q2 2026 | $8M | +36% |
| Q1 2026 | $13.8M | +7% |
| Q4 2025 | $35M | +56% |
| Q3 2025 | $786K | +$15.7M |
| Q2 2025 | $5.9M | +$8.5M |
| Q1 2025 | $12.9M | +$13.2M |
| Q4 2024 | $22.4M | -30% |
PDLB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PDLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +142K shares |
| 1 year | +2.2% | +515K shares |
| 3 years | +5.8% | +1.3M shares |
PDLB has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | $5.8M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
PDLB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.5x | High |
| Q2 2026 | 9.6x | High |
| Q1 2026 | 9.7x | High |
| Q4 2025 | 10.9x | High |
| Q3 2025 | 11.0x | High |
| Q2 2025 | 14.4x | High |
| Q1 2025 | 15.5x | High |
| Q4 2024 | 22.3x | High |
PDLB's net debt is about 11 years of its operating earnings (EBITDA), down from 11 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PDLB.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
PDLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.4 | Overbought |
| Stochastic | 76.7 | Neutral |
PDLB's weekly RSI is 70 (overbought) and its Stochastic is 77 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
PDLB PE vs Financial Services Sector
| Metric | PDLB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 10% below |
| PE % | 1 | 63 | 62 pts below |
PDLB is trading at 12x earnings, a 10% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
PDLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 5.8% above |
| 20 week MA | $20.6 | 7.8% above |
| 50 week MA | $18.6 | 19% above |
| 100 week MA | $16.1 | 38% above |
| 200 week MA | $12.7 | 75% above |
PDLB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
PDLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.8 | $10.4 | -30% |
| 2021 | $10.4 | $14.7 | +42% |
| 2022 | $14.7 | $9.51 | -35% |
| 2023 | $9.51 | $9.76 | +2.6% |
| 2024 | $9.76 | $12.8 | +31% |
| 2025 | $12.8 | $16.8 | +32% |
| 2026 YTD | $16.8 | $22.2 | +32% |
PDLB has the edge over IREN on returns for 2026, with the stronger performance.